Company Filing History:
Years Active: 2002
Title: Innovations of Kai-Chih Chang in MALToma Research.
Introduction
Kai-Chih Chang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical research, particularly in understanding mucosa-associated lymphoid tissue lymphoma of the stomach, commonly known as MALToma. His work focuses on genetic factors that may predispose individuals to this type of lymphoma.
Latest Patents
Kai-Chih Chang holds a patent for the invention titled "FldA gene and methods for detecting predisposition to mucosa-associated lymphoid tissue lymphoma of the stomach." This invention relates to the fldA gene, a putative flavodoxin gene whose expression is associated with MALToma. Notably, a G insertion at position 481 of the fldA gene was found to be more frequently observed in strains associated with MALToma than in other strains. This discovery provides a new method to identify patients at a higher risk of developing gastric MALToma.
Career Highlights
Chang is affiliated with the National Science Council, where he continues to advance research in the field of genetics and cancer predisposition. His work has implications for early detection and potential treatment strategies for MALToma.
Collaborations
He has collaborated with notable colleagues, including Jin-Town Wang and Chih-Shen Chang, to further enhance the research and development of methods related to his patent.
Conclusion
Kai-Chih Chang's innovative work in identifying genetic predispositions to MALToma represents a significant advancement in medical research. His contributions may lead to improved diagnostic methods and better patient outcomes in the future.